Tiber Creek Health Strategies is a Washington, D.C.-based lobbying firm representing Amgen, a large biotechnology company. Their filings show they lobby on drug pricing and pharmacy issues and on Medicare and Medicaid matters, including monitoring Public Law 119-21 (the One Big Beautiful Bill Act). They were paid about $150,000 across four filings and worked with B Hall Strategies.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr JAMES BRYANT HALL ii
The latest disclosures for this client.
B HALL STRATEGIES, LLC
Q2B HALL STRATEGIES, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
B HALL STRATEGIES, LLC
B HALL STRATEGIES, LLC
Q4B HALL STRATEGIES, LLC
Q3B HALL STRATEGIES, LLC
Q2B HALL STRATEGIES, LLC
RR